Personal Information
Entreprise/Lieu de travail
Greater Milwaukee Area United States
Profession
Medical Director, Early Phase Cancer Research Program, Patient-Centered Research
Secteur d’activité
Medical / Health Care / Pharmaceuticals
À propos
*Regarding LinkedIn*
I generally don't connect with people on LinkedIn that don't comment on why they think we should connect. See:
Use the “Favor Test” When You're Undecided About a LinkedIn Invitation [7/13/13] - @awsamuel @lifehacker http://ow.ly/AucoV
-----------
I am a board certified hematologist / oncologist. I am passionate about clinical trials, basic science and translational research. It is a tragedy that only 2-7% of adults participate in cancer clinical trials (Zon R. et al. ASCO statement on minimum standards and exemplary attributes of clinical trial sites. J Clin Oncol. 2008)
Improved clinical trial enrollment depends on well designed, interesting trials as well as inf
Mots-clés
#leusm
social media
#ebmt16
#lymsm
bone marrow transplant
#bmtsm
#mmsm
#hcsm
#mpnsm
Tout plus
Présentations
(1)J’aime
(19)Primer on using Snapchat at #AACR17 and other scientific meetings
Emil Lou, M.D., Ph.D, FACP
•
il y a 7 ans
Cancer Care in a Post Truth World
Matthew Katz
•
il y a 7 ans
Three things to know about pharma and twitter
Silja Chouquet
•
il y a 9 ans
Revealing ASCO's social DNA
Silja Chouquet
•
il y a 7 ans
Biosimilars discussion on Twitter
Silja Chouquet
•
il y a 7 ans
#radonc Journal Club on Twitter
Matthew Katz
•
il y a 8 ans
Digital Media Trends: Audience Architecture
W2O Group
•
il y a 8 ans
Social Media And Ethical Concerns For Healthcare Professionals
Marie Ennis-O'Connor
•
il y a 10 ans
The evolution of online cancer conversations
W2O Group
•
il y a 8 ans
SEOR 2015: Hashtags, #radonc and building community
Matthew Katz
•
il y a 8 ans
Disease specific hashtags for communication about cancer care
Matthew Katz
•
il y a 8 ans
Why Do We Need Twitter? For Health Professionals In Oncology, Hematology & Transplant
Navneet Majhail
•
il y a 9 ans
A healthcare case study of ASCO, Novartis and Boehringer conversation on twitter
Silja Chouquet
•
il y a 9 ans
Social media and medicine
Matthew Katz
•
il y a 13 ans
Medical professionalism 10 20
Matthew Katz
•
il y a 10 ans
Getting started in social media for healthcare professionals
Matthew Katz
•
il y a 10 ans
Twitter 101 Signing up: A Tutorial for Oncologists
Matthew Katz
•
il y a 10 ans
Twitter 102 Account Settings
Matthew Katz
•
il y a 10 ans
Twitter 103 Trolls, Malware and Spam
Matthew Katz
•
il y a 9 ans
Personal Information
Entreprise/Lieu de travail
Greater Milwaukee Area United States
Profession
Medical Director, Early Phase Cancer Research Program, Patient-Centered Research
Secteur d’activité
Medical / Health Care / Pharmaceuticals
À propos
*Regarding LinkedIn*
I generally don't connect with people on LinkedIn that don't comment on why they think we should connect. See:
Use the “Favor Test” When You're Undecided About a LinkedIn Invitation [7/13/13] - @awsamuel @lifehacker http://ow.ly/AucoV
-----------
I am a board certified hematologist / oncologist. I am passionate about clinical trials, basic science and translational research. It is a tragedy that only 2-7% of adults participate in cancer clinical trials (Zon R. et al. ASCO statement on minimum standards and exemplary attributes of clinical trial sites. J Clin Oncol. 2008)
Improved clinical trial enrollment depends on well designed, interesting trials as well as inf
Mots-clés
#leusm
social media
#ebmt16
#lymsm
bone marrow transplant
#bmtsm
#mmsm
#hcsm
#mpnsm
Tout plus